Join to View Full Profile
2201 Inwood Rd Seay Biomedical Building 2nd floorDallas, TX 75390
Phone+1 214-645-4673
Dr. Gerber is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2004 - 2007
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2000 - 2004
Weill Cornell MedicineClass of 2000
Certifications & Licensure
TX State Medical License 2002 - 2026
MD State Medical License 2004 - 2008
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Study of Bavituximab in Patients With Advanced Solid Tumor Malignancies Start of enrollment: 2005 Jun 01
- Romidepsin and Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Start of enrollment: 2009 Sep 01
- Clinical Trial of ARQ 761 in Advanced Solid Tumors Start of enrollment: 2011 Dec 29
- Join now to see all
Publications & Presentations
PubMed
- Concurrent and Consolidative Carboplatin Plus Nab-Paclitaxel or Paclitaxel in Locally Advanced NSCLC: A Multicenter, Randomized Clinical Trial.Yuanyuan Zhang, Aaron M Laine, Puneeth Iyengar, Kenneth D Westover, Jonathan E Dowell
International Journal of Radiation Oncology, Biology, Physics. 2025-06-01 - Mortality in a Diverse, Real-World Lung Cancer Screening Cohort.Mary E Gwin, Tanushree Prasad, Urooj Wahid, Sheena Bhalla, Song Zhang
Clinical Lung Cancer. 2025-05-13 - Financial Toxicity in Cancer Clinical Trials: An Issue in Need of Clarity and Solutions.Elizabeth K S Barksdale, Wendy Selig, Willyanne DeCormier Plosky, Erin Miller, Keri McDonough
Journal of Clinical Oncology. 2025-05-12
Journal Articles
- Treatment and Outcomes of Primary Pericardial Mesothelioma: A Contemporary Review of 103 Published CasesDavid E Gerber, Jonathan E Dowell, Clinical Lung Cancer
Lectures
- Impact of Prior Cancer on Eligibility for Plasma Cell Disorder (PCD) Clinical TrialsClinically Relevant Abstract2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Underlying host immune dysregulation in cancer patients developing immune-related adverse events.2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
Authored Content
- Treatment and Outcomes of Primary Pericardial Mesothelioma: A Contemporary Review of 103 Published CasesNovember 2018
Press Mentions
Texas Doctors Lost Connection with Patients’ Cancer Diagnoses. We Have It BackJune 6th, 2025- TMA Monitoring Approximately 2,800 Bills, Testifies for Patient Protections by Phil WestMarch 24th, 2025
- Antibody Designed to Fight Immunotherapy-Resistant CancersFebruary 14th, 2025
- Join now to see all
Grant Support
- UT Southwestern NCI National Clinical Trials Network (NCTN) LAPS - Funded Extension Supplement YR6UT SOUTHWESTERN MEDICAL CENTER2025–2026
- Finding the optimal balance of immunotherapy efficacy and toxicity.UT SOUTHWESTERN MEDICAL CENTER2020–2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
